N-alkyl-hydroxamic acid-isoindolyl compounds and their...

Details N-alkyl-hydroxamic acid-isoindolyl compounds and their... N-alkyl-hydroxamic acid-isoindolyl compounds and their...

2010-02-12

2011-12-13

Stockton, Laura L. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S417000

Reexamination Certificate

active

08076369

ABSTRACT:
The invention encompasses novel N-alkyl-hydroxamic acid-isoindolyl compounds, pharmaceutical compositions of these compounds, and methods of using these compounds and compositions for treatment or prevention of various diseases and disorders, for example, diseases associated with PDE4.

REFERENCES:
patent: 5605914 (1997-02-01), Muller et al.
patent: 6214857 (2001-04-01), Muller et al.
patent: 6667316 (2003-12-01), Man et al.
patent: 6699899 (2004-03-01), Man et al.
patent: WO 02/081447 (2002-10-01), None
Souillac, et al., Characterization of Delivery Systems, Differential Scanning Calorimetry, Encyclopedia of Controlled Drug Delivery, 1999, John Wiley & Sons, pp. 212-227.
Vippagunta et al., Advanced Drug Delivery Reviews, 48 (2001), pp. 3-26.
Golub et al., Science, vol. 286, Oct. 15, 1999, pp. 531-537.
Abstract of Timberidou et al., Expert Rev Anticancer Ther., 2(3): 277-86 (2002).
Abstract of Iki et al., Exp Hematol., 25(1): 26-33 (1997).
Abstract of Sriram et al., FASEB J., 16(11): 1474-1476 (2002).
Abstract of Leem et al., J Pain, 3(1): 45-49 (2002).
Abstract of Takeuchi et al., Dig. Dis. Sci., 47(9): 2070-2078 (2002).
Abstract of Sharma et al., Heart Fail Monit., 2(2): 42-47 (2001).
Abstract of Int J Neuropsychopharmacol., 5(4): 375-388 (2002).
Abstract of Griffiths et al., Br J Dermatol., 147(2): 299-307 (2002).
Abstract of Doganay et al., Eye, 16(2): 163-170 (2002).
Abstract of Alecu et al., Rom J Intern Med., 38-39: 83088 (2000-2001).
Abstract of Dinter, BioDrugs, 13(2): 87-94 (2000).
Abstract of Chiou, J Ocul Pharmacol Ther., 17(2): 189-198 (2001).
Abstract of Aggarwal et al., Curr Drug Targets Inflamm Allergy, 1(4): 327-341 (2002).
Abstract of Roselli et al., Oncology, 65(2): 132-138 (2003).
Abstract of Orosz et al., J Exp Med., 177(5): 1391-1398 (1993).
Abstract of Qin et al., J Exp Med., 178(1): 335-360 (1993).
Ueno et al., British Journal of Cancer, 92: 1690-1695 (2005).

Affiliated with

Also associated with

Rating

N-alkyl-hydroxamic acid-isoindolyl compounds and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-alkyl-hydroxamic acid-isoindolyl compounds and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-alkyl-hydroxamic acid-isoindolyl compounds and their... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4268523